| Q-LINEA AB |
| Schweden |
| Gesundheit |
| SE0025420714 / A41DDP |
| 3F80 (Frankfurt) |
| FRA:3F80, ETR:3F80, 3F80:GR |
| - |
| https://qlinea.com/ |
|
Q-linea AB is a diagnostics company specializing in innovative infection diagnostics solutions that benefit patients, healthcare providers, and society by enabling rapid diagnosis and treatment of severe infections like sepsis. Founded in 2008 by sci..
>Volltext.. |
| 38.45 Mio. EUR |
| 15.71 Mio. EUR |
| 1.04 Mio. EUR |
| -15.42 Mio. EUR |
| -17.07 Mio. EUR |
| -3.47 EUR |
| 0.55 Mio. EUR |
| 24.15 Mio. EUR |
| -15.17 Mio. EUR |
| 8.66 |
| 369.86% |
| 15.87% |
| - |
| - |
| - |
| - |
| Q-LINEA, Q LINEA, QLINEA |
| 02.04.26 |
|